Prothena
PRTA
#7703
Rank
โ‚ฌ0.38 B
Marketcap
7,49ย โ‚ฌ
Share price
-2.14%
Change (1 day)
-13.48%
Change (1 year)

EPS for Prothena (PRTA)

EPS in 2026 (TTM): -0,71ย โ‚ฌ

According to Prothena's latest financial reports the company's current EPS (TTM) is -0,76ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -4,14ย โ‚ฌ a decrease over its 2024 EPS that were of -2,08ย โ‚ฌ.

EPS history for Prothena from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,71ย โ‚ฌ-82.89%
2025-4,14ย โ‚ฌ99.12%
2024-2,08ย โ‚ฌ-17.69%
2023-2,53ย โ‚ฌ10.8%
2022-2,28ย โ‚ฌ-279.86%
20211,27ย โ‚ฌ-149.82%
2020-2,54ย โ‚ฌ43.08%
2019-1,78ย โ‚ฌ-50.51%
2018-3,59ย โ‚ฌ-2.96%
2017-3,70ย โ‚ฌ-12.88%
2016-4,25ย โ‚ฌ77.19%
2015-2,40ย โ‚ฌ3187.5%
2014-0,07293ย โ‚ฌ-96.4%
2013-2,02ย โ‚ฌ-10.16%
2012-2,25ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amarin Corporation
AMRN
-0,91ย โ‚ฌ 20.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Alnylam Pharmaceuticals
ALNY
18,06ย โ‚ฌ-2,486.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
-0,0000000000ย โ‚ฌ-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland